Functional effects of genetic variants in the 11β-hydroxylase (CYP11B1) gene

被引:15
|
作者
Barr, Marianne
MacKenzie, Scott M.
Wilkinson, Donna M.
Holloway, Christine D.
Friel, Elaine C.
Miller, Stephen
MacDonald, Tom
Fraser, Robert
Connell, John M. C.
Davies, Eleanor
机构
[1] Univ Glasgow, BHF GCRC, Div Cardiovasc & Med Sci, Blood Pressure Grp, Glasgow G12 8TA, Lanark, Scotland
[2] Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Dundee DD1 9SY, Scotland
基金
英国医学研究理事会;
关键词
ALDOSTERONE SYNTHASE GENE; CONGENITAL ADRENAL-HYPERPLASIA; SINGLE-NUCLEOTIDE POLYMORPHISMS; ESSENTIAL-HYPERTENSION; ANGIOTENSIN-II; BLOOD-PRESSURE; AMINO-ACID; DEFICIENCY; MUTATIONS; PREVALENCE;
D O I
10.1111/j.1365-2265.2006.02673.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective We previously described an association between the -344C/T 5'-untranslated region (UTR) polymorphism in the CYP11B2 (aldosterone synthase) gene and hypertension with a raised aldosterone to renin ratio (ARR); the same genetic variant is also associated with impaired adrenal 11 beta-hydroxylase efficiency. The -344 polymorphism does not seem to be functional, so is likely to be in linkage with variants in CYP11B1 that determine the associated variation in 11 beta-hydroxylase efficiency. We therefore aimed to determine whether there is an association between CYP11B1 variants and hypertension and/or an altered ARR. Design and measurements We screened 160 subjects divided into four groups, normotensive controls, unselected hypertensive subjects, and hypertensive subjects with either a high (>= 750) or low ARR (<= 200), for variants in the coding region of CYP11B1 by single-stranded conformation polymorphism (SSCP) and direct sequencing. The effects of these variants on enzyme function were assessed by conversion of 11-deoxycortisol to cortisol and 11-deoxycorticosterone (DOC) to corticosterone. Results Eight novel missense mutations were identified in the CYP11B1 gene that alter the encoded amino acids: R43Q, L83S, H125R, P135S, F139L, L158P, L186V and T196A. In each case they were heterozygous changes. However, no mutations were identified that could account for hypertension and/or a raised ARR. The variants L158P and L83S severely impaired enzyme function while R43Q, F139L, P135S and T196A enzymes resulted in product levels that were approximately 30-50% that of wild-type levels. The variant enzymes H125R and L186V resulted in substrate-specific alterations in enzyme function. H125R decreased conversion of 11-deoxycortisol to cortisol and L186V increased 11-deoxycortisol conversion. Neither had an effect on the conversion of DOC to corticosterone. Conclusion No variants were identified in the coding region of CYP11B1 that could account for hypertension and/or a raised ARR. However, this in vitro study identifies the importance of these affected residues to enzyme function and will inform subsequent studies of structure-function relationships.
引用
收藏
页码:816 / 825
页数:10
相关论文
共 50 条
  • [41] A Novel Mutation in the CYP11B1 Gene Causes Steroid 11β-Hydroxylase Deficient Congenital Adrenal Hyperplasia with Reversible Cardiomyopathy
    Alqahtani, Mohammad A.
    Shati, Ayed A.
    Zou, Minjing
    Alsuheel, Ali M.
    Alhayani, Abdullah A.
    Al-Qahtani, Saleh M.
    Gilban, Hessa M.
    Meyer, Brain F.
    Shi, Yufei
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [42] A novel nonsense mutation in the CYP11B1 gene from a subject with the steroid 11β-hydroxylase form of congenital adrenal hyperplasia
    Kuribayashi, I
    Massa, G
    van den Tooren-de Groot, HK
    Oostdijk, W
    Wit, JM
    Shizuta, Y
    ENDOCRINE RESEARCH, 2003, 29 (04) : 377 - 381
  • [43] Genetic Analyses of the Chimeric CYP11B1/CYP11B2 Gene in a Korean Family with Glucocorticoid-Remediable Aldosteronism
    Lee, Ihn Suk
    Kim, Seul Young
    Jang, Hye Won
    Kim, Min Kyeong
    Lee, Ju Hee
    Lee, Yun Hyeong
    Jo, Young Suk
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (09) : 1379 - 1383
  • [44] Splicing analysis of CYP11B1 mutation in a family affected with 11β-hydroxylase deficiency: case report
    Pattaranatcha Charnwichai
    Patra Yeetong
    Kanya Suphapeetiporn
    Vichit Supornsilchai
    Taninee Sahakitrungruang
    Vorasuk Shotelersuk
    BMC Endocrine Disorders, 16
  • [45] EXPRESSION OF THE HUMAN 11-BETA-HYDROXYLASE GENES, CYP11B1 AND CYP11B2, IN AN ALDOSTERONE-SECRETING TUMOR
    CURNOW, KM
    WHITE, PC
    CLINICAL RESEARCH, 1991, 39 (02): : A270 - A270
  • [46] Splicing analysis of CYP11B1 mutation in a family affected with 11β-hydroxylase deficiency: case report
    Charnwichai, Pattaranatcha
    Yeetong, Patra
    Suphapeetiporn, Kanya
    Supornsilchai, Vichit
    Sahakitrungruang, Taninee
    Shotelersuk, Vorasuk
    BMC ENDOCRINE DISORDERS, 2016, 16
  • [47] Novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11β-hydroxylase deficiency
    Merke, DP
    Tajima, T
    Chhabra, A
    Barnes, K
    Mancilla, E
    Baron, J
    Cutler, GB
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (01): : 270 - 273
  • [48] A Chinese patient with 11β-hydroxylase deficiency due to novel compound heterozygous mutation in CYP11B1 gene: a case report
    Xianxian Yuan
    Lin Lu
    Shi Chen
    Jun Jiang
    Xiangqing Wang
    Zhihui Liu
    Huijuan Zhu
    Hui Pan
    Zhaolin Lu
    BMC Endocrine Disorders, 18
  • [49] A chimeric CYP11B1/CYP11B2 gene in glucocorticoid-insuppressible familial hyperaldosteronism
    Ise, T
    Shimoda, A
    Takakuwa, H
    Kato, T
    Izumiya, Y
    Shimizu, K
    Suzuki, T
    Sasano, H
    Yokoyama, H
    Kobayashi, K
    CLINICAL ENDOCRINOLOGY, 2001, 55 (01) : 131 - 134
  • [50] The human steroid hydroxylases CYP11B1 and CYP11B2
    Bureik, M
    Lisurek, M
    Bernhardt, R
    BIOLOGICAL CHEMISTRY, 2002, 383 (10) : 1537 - 1551